Combined single session EUS+/- ERCP for biliary stone disease. Experience from a large tertiary UK centre
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S161-S162
DOI: 10.1055/s-0044-1783045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von N. Pantzaris und 4 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Aims
Single session EUS/ERCP for biliary stone disease has the advantages of obtaining immediate, real-time information from EUS, administering only one sedation for both diagnosing and treating biliary stones, and potentially avoiding an unnecessary ERCP in the event of a spontaneous passage of CBD stones. The objective of this study was to review the combined EUS-ERCP procedures for biliary stone disease and how it alters the proportion of patients undergoing subsequent ERCP. A secondary objective was to assess the imaging modalities that led to the ERCP request and any correlation between the EUS findings, liver function tests (LFTs), abdominal ultrasound (USS)/CT/MRCP findings and scan-to-ERCP time.
Methods
Data were retrospectively collected from the endoscopy and patient record system as well as a prospectively maintained database of all ERCP and EUS procedures of a large tertiary centre in the UK during a 12-month period, from 1/10/2022 to 30/9/2023 with a 30-day follow-up period.
Results
During the study period, 712 ERCPs were performed, from which 379/712 were for biliary stone disease (53.2%). 103 patients had EUS+-ERCP for stones. The most recent imaging modality was MRCP for 72/103 patients, CT for 20/103, USS for 10/103 and EUS for 1/103. Median days of most recent imaging to ERCP was 28(8;82). 78/103 patients had a CBD dilatation on their most recent imaging modality and 76/103 patients had a stone identified. 74/103 patients had an abnormal ALP [median 327(204;463) on the ERCP request and 46/103 an abnormal bilirubin [median 61(37;85)]. 37/103 patients (35.9%) did not proceed to an ERCP as it was not indicated from the EUS outcome. CBD dilatation on most recent imaging was significantly associated with proceeding to ERCP (p=0.007). Abnormal bilirubin at the time of the request was also associated with proceeding to ERCP (p=0.009) but not ALP. Pre-procedure repeat LFTs that were normal or improving were significantly associated with not proceeding to ERCP (p=0.024). Only 1/37 patient who did not proceed to ERCP had a biliary event in the follow up period. This was a biliary pain episode with jaundice post cholecystectomy, presumed to be from a dropped stone post operatively and he underwent an ERCP. [ 1 ] [ 2 ] [ 3 ] [ 4 ] [ 5 ] [ 6 ] [ 7 ] 5/64 patients who had an ERCP had a procedure related complication; 2/5 had post ERCP pancreatitis, 2/5 had cholangitis and 1/5 had a small post sphincterotomy bleed. No patient in the EUS only group had a procedure related complication.
Conclusions
Targeted EUS to confirm the presence of CBD stones when there is clinical doubt based on the date and results of imaging and LFTs, is a safe and efficient way to avoid unnecessary ERCPs. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Pantzaris, N., Everett, S., Huggett, M., Paranandi, B., & Aaron, O. (2024). Combined single session EUS+/- ERCP for biliary stone disease. Experience from a large tertiary UK centre. Endoscopy, 56(S 02 S 02), S161-S162. https://doi.org/10.1055/s-0044-1783045
Vancouver
Pantzaris N, Everett S, Huggett M, Paranandi B, Aaron O. Combined single session EUS+/- ERCP for biliary stone disease. Experience from a large tertiary UK centre. Endoscopy. 2024;56(S 02 S 02):S161-S162. doi:10.1055/s-0044-1783045
BibTeX
@article{Pantzaris2024,
author = {Pantzaris, N. and Everett, S. and Huggett, M. and Paranandi, B. and Aaron, O.},
title = {Combined single session EUS+/- ERCP for biliary stone disease. Experience from a large tertiary UK centre},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S161--S162},
doi = {10.1055/s-0044-1783045}
}
EUVIMED